BillTrack50 logo
Free Signup Login
Bill

Bill > HR2940

US HR2940

US HR2940
PASTEUR Act Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2023

summary

Introduced
04/27/2023
In Committee
04/28/2023
Crossed Over
Passed
Dead
01/03/2025

Introduced Session

118th Congress

Bill Summary

A BILL To amend title III of the Public Health Service Act to establish a program to develop antimicrobial innovations targeting the most challenging pathogens and most threatening infections, and for other purposes.

AI Summary

This bill, the "Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2023" or the "PASTEUR Act of 2023", establishes a program to develop antimicrobial innovations targeting the most challenging pathogens and most threatening infections. It creates a Committee on Critical Need Antimicrobials to develop a list of infections for which new antimicrobial drug development is needed, and regulations for favored characteristics of critical need antimicrobial drugs. The bill also allows for transitional subscription contracts and establishes a Critical Need Antimicrobial Advisory Group. It sets up a Subscription Contract Office to manage subscription contracts for critical need antimicrobial drugs, with requirements for sponsors and limitations on revenue. The bill also provides funding and directs the Centers for Disease Control and Prevention to enhance antimicrobial use and resistance surveillance and reporting.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (63)

Drew Ferguson (R)*,  Mark Amodei (R),  Jake Auchincloss (D),  Don Bacon (R),  Nanette Barragán (D),  Lisa Blunt Rochester (D),  Larry Bucshon (R),  Michael Burgess (R),  Mike Carey (R),  Buddy Carter (R),  Troy Carter (D),  Sheila Cherfilus-McCormick (D),  Juan Ciscomani (R),  Yvette Clarke (D),  Ben Cline (R),  Angie Craig (D),  Jason Crow (D),  Henry Cuellar (D),  Don Davis (D),  Diana DeGette (D),  Jeff Duncan (R),  Brian Fitzpatrick (R),  Chuck Fleischmann (R),  Dan Goldman (D),  Jenniffer González (R),  Mark Green (R),  Bill Johnson (R),  Tom Kean (R),  Mike Kelly (R),  Ann Kuster (D),  John Larson (D),  Jake LaTurner (R),  Susie Lee (D),  Mike Levin (D),  Nicole Malliotakis (R),  Tracey Mann (R),  Doris Matsui (D),  Lucy McBath (D),  Jim McGovern (D),  Dan Meuser (R),  Mariannette Miller-Meeks (R),  Frank Mrvan (D),  Greg Murphy (R),  Joe Neguse (D),  Eleanor Holmes Norton (D),  Jay Obernolte (R),  Jimmy Panetta (D),  Scott Peters (D),  Mike Quigley (D),  Jamie Raskin (D),  Deborah Ross (D),  María Salazar (R),  Kim Schrier (D),  David Schweikert (R),  Austin Scott (R),  Terri Sewell (D),  Adrian Smith (R),  Chris Smith (R),  Paul Tonko (D),  Lori Trahan (D),  David Valadao (R),  Jeff Van Drew (R),  Brad Wenstrup (R), 

Last Action

Referred to the Subcommittee on Health. (on 04/28/2023)

Bill Topics

Health
  • ‐ Communicable Diseases
  • ‐ Regulation of Drug Industry and Pharmacies
  • ‐ Research and Development
(2 Companion Bills)

bill text

bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location Created
State Bill Page https://www.congress.gov/bill/118th-congress/house-bill/2940/all-info 04/28/2023
BillText https://www.congress.gov/118/bills/hr2940/BILLS-118hr2940ih.pdf 05/10/2023
Loading...